Over 95,000 renal transplantation procedures were completed in 2021. Invasive
aspergillosis (IA) affects about 1 in 250 to 1 in 43 renal transplant recipients. About 50% of …

Detection of galactomannan has become widely available for diagnosing invasive
aspergillosis. The test characteristics, using the Platelia™ enzyme-immunoassay, have …

Background There is lack of recent multicenter epidemiological data on invasive
aspergillosis (IA) among solid organ transplant recipient (SOT r) in the mold‐acting …

Although a wide variety of pathogens are associated with invasive mould diseases,
Aspergillus spp. have historically been one of the most common causative organisms. Most …

CMV infection is associated with increased risk of IFD in posttransplant recipients because
of a number of overlapping and virus-specific risk factors. Better understanding of how CMV …

The prognostic factors and optimal therapy for invasive pulmonary aspergillosis (IPA) after
kidney transplantation (KT) remain poorly studied. We included in this multinational …

Background: Invasive fungal infection (IFI) is one of the leading causes of early death after
renal transplantation. Voriconazole (VRC) is the first-line drug of IFI. Because of the large …

Invasive fungal infections constitute an important cause of morbidity and mortality in solid
organ transplantation recipients. Since solid organ transplantation is an effective therapy for …

Background: Cytomegalovirus (CMV) and invasive aspergillosis (IA) cause high morbidity
and mortality in solid organ transplant (SOT) recipients. There are conflicting data with …

Background Kidney transplant recipients are at increased risk for invasive aspergillosis (IA),
a disease with poor outcomes and substantial economic burden. We aimed to determine risk …